RE:RE:RE:Health Minister Hey all, everything is availble in the Sedar documents. Please do DD.
First off 14 day per person but they will be doing staggared enrolment. Difficult to predict first person to start the trial to last person, but it would be reasonable to think it could be 30-90 days apart.
If you are serious about this investment you should all read the following:
| Feb 22 2019 | 10:41:17 ET | | PDF | 270 K |
Very good details with timelines here. which includes: A top-line data read-out of the Phase 2B dose-ranging, efficacy study for ATB-346 is expected in calendar Q3 2019.
Also you should be reading the MD&As - you'd see the details of the milestone payments are in the "Three and Dix months ended Sept 30, 2018" MD&A
Under the terms of license agreement 2 Antibe will be issued payment upon achievement of the following milestones: • US$1,000,000 upon receipt of regulatory approval from the Food and Drug Administration in the USA; • US$1,000,000 upon market launch of ATB-346 or the first offer for sale of ATB-346 in the Region; • US$1,000,000 upon total net sales in the Region exceeding US$5,000,000 for the first time; • US$1,000,000 upon total net sales in the Region exceeding US$10,000,000 for the first time; • US$1,000,000 upon total net sales in the Region exceeding US$20,000,000 for the first time; • US$1,000,000 upon total net sales in the Region exceeding US$30,000,000 for the first time; • US$1,500,000 upon total net sales in the Region exceeding US$40,000,000 for the first time; and • US$1,500,000 upon total net sales in the Region exceeding US$50,000,000 for the first time